Clinical Trials Logo
  1. Home
  2. Urinary Incontinence, Stress
  3. NCT00244296

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress Clinical Trial

Official title:
A Double-Blind, Stratified, Randomised, Parallel, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy and Safety of Duloxetine (20 mg Bid for 2 Weeks Escalating to 40 mg Bid) for up to 12 Weeks, Compared to Placebo, in Community-Dwelling Elderly Women > or = 65 Years of Age With Symptoms of Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence.

Clinical Trial Summary

The purpose of this study is to determine how effective duloxetine is in treating women who are 65 years of age or older with symptoms of stress urinary incontinence, or with a combination of stress urinary incontinence and urge urinary incontinence symptoms.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00244296
Study type Interventional
Source Eli Lilly and Company
Contact
Status Completed
Phase Phase 4
Start date October 2005
Completion date January 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT02001714 - Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms N/A
Not yet recruiting NCT00523068 - Pharmacological vs Surgical Treatment for Mixed Incontinence Phase 4
Completed NCT00904969 - A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence N/A
Completed NCT00190814 - Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge. Phase 3
Completed NCT00190827 - Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine) Phase 3
Terminated NCT00247286 - Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial. Phase 4
Completed NCT01959347 - Combined Treatment for Mixed Incontinence Phase 3
Not yet recruiting NCT05570071 - A Study of the Use of Vaginal Radiofrequency Therapy in Treatment of SUI. N/A
Completed NCT02334878 - Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence Phase 3
Completed NCT01382602 - Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study Phase 3
Completed NCT03296462 - Hip External Rotation Physical Therapy Trial N/A
Recruiting NCT02750878 - Surgical Consent Process for Trans-obturator Tape Slings. N/A
Completed NCT02296099 - Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence Phase 4
Completed NCT02599051 - Transobturator Verus Single Incision Slings N/A
Completed NCT00138749 - An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence. Phase 2
Terminated NCT03614611 - Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence N/A
Completed NCT03722719 - The Knack on Female Stress Urinary Incontinence N/A
Active, not recruiting NCT02275728 - Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence N/A
Terminated NCT01358214 - Quality of Life After Tension Free Transvaginal Sling / Tape Operation With a Titanized Surgical Tape (TiLOOP® Tape) N/A
Active, not recruiting NCT01323426 - Treatment of Stress Urinary Incontinence by Injection of Autologous Muscle Fibers Into the Urethral Sphincter. Phase 1/Phase 2